TW260615B - - Google Patents

Info

Publication number
TW260615B
TW260615B TW82102545A TW82102545A TW260615B TW 260615 B TW260615 B TW 260615B TW 82102545 A TW82102545 A TW 82102545A TW 82102545 A TW82102545 A TW 82102545A TW 260615 B TW260615 B TW 260615B
Authority
TW
Taiwan
Application number
TW82102545A
Other languages
Chinese (zh)
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL10290592A external-priority patent/IL102905A/en
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of TW260615B publication Critical patent/TW260615B/zh

Links

TW82102545A 1992-08-21 1993-04-03 TW260615B (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10290592A IL102905A (en) 1991-08-30 1992-08-21 Ophthalmic composition containing vitamin b-12 for neutralizing residual peroxide

Publications (1)

Publication Number Publication Date
TW260615B true TW260615B (https=) 1995-10-21

Family

ID=51626704

Family Applications (1)

Application Number Title Priority Date Filing Date
TW82102545A TW260615B (https=) 1992-08-21 1993-04-03

Country Status (1)

Country Link
TW (1) TW260615B (https=)

Similar Documents

Publication Publication Date Title
DK0603481T3 (https=)
DK0644844T3 (https=)
DK0596750T3 (https=)
DK0576346T3 (https=)
BR9207065A (https=)
DK0553681T3 (https=)
DK0576097T3 (https=)
DK0590732T3 (https=)
DE9207553U1 (https=)
AU632452B2 (https=)
TW260615B (https=)
AU2098792A (https=)
BRPI9204323A2 (https=)
AU2629492A (https=)
CN3011927S (https=)
AU1849392A (https=)
AU1862992A (https=)
AU1933792A (https=)
AU2053892A (https=)
AU2065592A (https=)
AU1737992A (https=)
AU2202592A (https=)
AU2281492A (https=)
AU1711092A (https=)
AU1610792A (https=)

Legal Events

Date Code Title Description
MC4A Revocation of granted patent